Reddit tells a different story and offers mostly negative sentiment, which, while worth factoring in, is common for GLP-1 clinics on that platform
A brief overview of the mechanosensory lateral line system and the contributions to this volume, in The Mechanosensory Lateral Line: Neurobiology and Evolution (New York: Springer), 35
10.1097/IJG.0000000000000829 J
Commonly reported issues with early dosing include: Increased Nausea: This is the most frequent side effect
In other words, having slightly elevated pancreatic enzymes while on a GLP-1 agonist almost never means you are developing pancreatitis
FDAs FAERS database documented exponential increases in gastroparesis reports following Ozempics approval, with emergency department visits for semaglutide-related complications reaching 25,000 cases between 2022-2023 alone